CT strain metrics allow for earlier diagnosis of bronchiolitis obliterans syndrome after hematopoietic cell transplant.

Autor: Sharifi H; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Bertini CD; Division of Pulmonary and Critical Care Medicine, University of Texas Health Science Center, Houston, TX., Alkhunaizi M; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Hernandez M; Division of Hospital Medicine, Northwestern University, Chicago, IL., Musa Z; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Borges C; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Turk I; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Bashoura L; Department of Pulmonary Medicine, MD Anderson Cancer Center, Houston, TX., Dickey BF; Department of Pulmonary Medicine, MD Anderson Cancer Center, Houston, TX., Cheng GS; Division of Pulmonary, Critical Care and Sleep Medicine, Fred Hutchinson Cancer Center, Seattle, WA., Yanik G; Blood and Marrow Transplant Division, University of Michigan Health, Ann Arbor, MI., Galban CJ; Department of Radiology, Blood and Marrow Transplant Division, University of Michigan Health, Ann Arbor, MI., Guo HH; Department of Radiology, Stanford University School of Medicine, Stanford, CA., Godoy MCB; Department of Pulmonary Medicine, MD Anderson Cancer Center, Houston, TX., Reinhardt JM; Department of Radiology, University of Iowa, Iowa City, IA., Hoffman EA; Department of Radiology, University of Iowa, Iowa City, IA., Castro M; Division of Pulmonary, Critical Care and Sleep Medicine, Kansas University Medical Center, Kansas City, KS., Rondon G; Department of Pulmonary Medicine, MD Anderson Cancer Center, Houston, TX., Alousi AM; Department of Pulmonary Medicine, MD Anderson Cancer Center, Houston, TX., Champlin RE; Department of Pulmonary Medicine, MD Anderson Cancer Center, Houston, TX., Shpall EJ; Department of Pulmonary Medicine, MD Anderson Cancer Center, Houston, TX., Lu Y; Department of Biomedical Data Sciences, Stanford University, Stanford, CA., Peterson S; VIDA Diagnostics, Inc, Coralville, IA., Datta K; Department of Radiology, Stanford University School of Medicine, Stanford, CA., Nicolls MR; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Hsu J; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA., Sheshadri A; Division of Pulmonary and Critical Care Medicine, University of Texas Health Science Center, Houston, TX.

Publikováno v: Blood advances [Blood Adv] 2024 Oct 08; Vol. 8 (19), pp. 5156-5165.

A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD.

Autor: Qayed M; Emory University School of Medicine, Atlanta, Georgia; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, Georgia. Electronic address: mqayed@emory.edu., Kapoor U; The Tisch Cancer Institute and Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Gillespie S; Pediatric Biostatistics Core, Department of Pediatrics, Emory University, Atlanta, Georgia., Westbrook A; Pediatric Biostatistics Core, Department of Pediatrics, Emory University, Atlanta, Georgia., Aguayo-Hiraldo P; Division of Hematology, Oncology, and BMT, Children's Hospital Los Angeles, Los Angeles, California., Ayuk FA; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Aziz M; The Tisch Cancer Institute and Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Baez J; The Tisch Cancer Institute and Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Choe H; Ohio State University Wexner Medical Center, Columbus, Ohio., DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, Massachusetts., Etra A; The Tisch Cancer Institute and Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Grupp SA; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Hexner E; Blood and Marrow Transplantation Program, Abramson Cancer Center and the Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania., Holler E; Department of Hematology and Oncology, Internal Medicine III, University of Regensburg, Regensburg, Germany., Hogan WJ; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Kowalyk S; The Tisch Cancer Institute and Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Merli P; Ospedale Pediatrico Bambino Gesú, IRCCS, Rome, Italy., Morales G; The Tisch Cancer Institute and Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Nakamura R; Hematology/Hematopoietic Cell Transplant, City of Hope National Medical Center, Duarte, California., Pulsipher MA; Division of Hematology, Oncology, and BMT, Children's Hospital Los Angeles, Los Angeles, California; Division of Hematology and Oncology, Intermountain Primary Children's Hospital, Huntsman Cancer Institute at the Spencer Fox Eccles School of Medicine at the University of Utah, Salt Lake City, Utah., Schechter T; Division of Hematology/Oncology/BMT, The Hospital for Sick Children, Toronto, ON, Canada., Shah J; The Tisch Cancer Institute and Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Spyrou N; The Tisch Cancer Institute and Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Srinagesh HK; The Tisch Cancer Institute and Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Wölfl M; Pediatric Blood and Marrow Transplantation Program, Children's Hospital, University of Würzburg, Würzburg, Germany., Yanik G; Pediatric Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, Michigan., Young R; The Tisch Cancer Institute and Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Kitko CL; Pediatric Blood and Marrow Transplant Program, Vanderbilt University Medical Center, Nashville, Tennessee., Ferrara JLM; The Tisch Cancer Institute and Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York., Levine JE; The Tisch Cancer Institute and Division of Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, New York.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jun; Vol. 30 (6), pp. 603.e1-603.e11. Date of Electronic Publication: 2024 Mar 27.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk Score.

Autor: Vasbinder A; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI., Catalan T; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI., Anderson E; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI., Chu C; Rush University Medical College, Rush University Chicago IL., Kotzin M; Rush University Medical College, Rush University Chicago IL., Murphy D; Department of Pharmacy Rush University Medical Center Chicago IL., Cheplowitz H; Department of Pharmacy Rush University Medical Center Chicago IL., Diaz KM; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI., Bitterman B; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI., Pizzo I; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI., Huang Y; Department of Biostatistics, School of Public Health University of Michigan Ann Arbor MI., Xie J; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI., Hoeger CW; Division of Cardiology, Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA., Kaakati R; Department of Internal Medicine University of Michigan Ann Arbor MI., Berlin HP; Division of Cardiology, Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA., Shadid H; Division of Cardiology, Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA., Perry D; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI., Pan M; Division of Cardiology, Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA., Takiar R; Division of Hematology/Oncology, Department of Internal Medicine University of Michigan Ann Arbor MI., Padalia K; Division of Cardiology, Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA., Mills J; Division of Cardiology, Department of Medicine Beth Israel Deaconess Medical Center, Harvard Medical School Boston MA., Meloche C; Division of Cardiovascular Medicine Texas Heart Institute Houston TX., Bardwell A; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI., Rochlen M; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI., Blakely P; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI., Leja M; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI., Banerjee M; Department of Pharmacy Rush University Medical Center Chicago IL., Riwes M; Division of Cardiovascular Medicine Texas Heart Institute Houston TX., Magenau J; Division of Hematology/Oncology, Department of Internal Medicine University of Michigan Ann Arbor MI., Anand S; Division of Hematology/Oncology, Department of Internal Medicine University of Michigan Ann Arbor MI., Ghosh M; Division of Hematology/Oncology, Department of Internal Medicine University of Michigan Ann Arbor MI., Pawarode A; Division of Hematology/Oncology, Department of Internal Medicine University of Michigan Ann Arbor MI., Yanik G; Division of Hematology/Oncology, Department of Internal Medicine University of Michigan Ann Arbor MI., Nathan S; Division of Hematology, Oncology and Cell Therapy, Department of Internal Medicine Rush University Medical Center Chicago IL., Maciejewski J; Division of Hematology/Oncology, Department of Internal Medicine University of Michigan Ann Arbor MI., Okwuosa T; Division of Cardiology, Department of Internal Medicine Rush University Medical Center Chicago IL., Hayek SS; Division of Cardiovascular Medicine, Department of Internal Medicine University of Michigan Ann Arbor MI.

Publikováno v: Journal of the American Heart Association [J Am Heart Assoc] 2024 Jan 02; Vol. 13 (1), pp. e033599. Date of Electronic Publication: 2023 Dec 29.

Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation.

Autor: Riwes MM; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA. mmriwes@med.umich.edu., Golob JL; Department of Internal Medicine, Division of Infectious Disease, University of Michigan, Ann Arbor, MI, USA., Magenau J; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA., Shan M; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA., Dick G; Department of Earth & Environmental Sciences, University of Michigan, Ann Arbor, MI, USA., Braun T; Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA., Schmidt TM; Department of Internal Medicine, Division of Infectious Disease, University of Michigan, Ann Arbor, MI, USA., Pawarode A; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA., Anand S; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA., Ghosh M; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA., Maciejewski J; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA., King D; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA., Choi S; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA., Yanik G; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA., Geer M; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA., Hillman E; Department of Internal Medicine, Division of Infectious Disease, University of Michigan, Ann Arbor, MI, USA., Lyssiotis CA; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA., Tewari M; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA., Reddy P; Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan, Rogel Cancer Center, Ann Arbor, MI, USA. pavan.reddy@bcm.edu.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA. pavan.reddy@bcm.edu.

Publikováno v: Nature medicine [Nat Med] 2023 Nov; Vol. 29 (11), pp. 2805-2813. Date of Electronic Publication: 2023 Oct 19.